Business Today14d
'India can’t be left behind...': Bhavish Aggarwal's Krutrim deploys DeepSeek AI on Indian servers, claims lowest pricing
Google Cloud has also made them available through its Vertex AI Platform. Aggarwal’s ambitions for Krutrim go far beyond cloud deployment. Since its inception, the company has faced scrutiny ...
Hosted on MSN14d
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline challenges
While CF remains Vertex's primary revenue driver, the company is actively working to diversify its portfolio. Several key pipeline programs ... Investing.com’s ProPicks, an AI-driven service ...
Investing14d
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline challenges
While CF remains Vertex's primary revenue driver, the company is actively working to diversify its portfolio. Several key pipeline programs and potential ... Investing.com’s ProPicks, an AI-driven ...
Seeking Alpha14d
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
With multiple ongoing clinical trials and a robust pipeline, Vertex is poised to exceed conservative analyst revenue projections, making the stock a STRONG BUY with a 12-month price of $550/share.
moneycontrol.com14d
Bhavish Aggarwal's Krutrim deploys DeepSeek AI models on its cloud servers
It is also available on Google Cloud's Vertex AI Platform. Aggarwal also hinted at major announcements regarding its AI research and innovations. On February 4, Krutrim will reveal details about ...
WHAS11 News14d
FDA approves Journavx, the first new painkiller in over two decades
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...